Patients whose tumor contained a maximum of 42 % of GLUT-1high melanoma cells showed a median survival of 11 months, while patients with higher percentages of GLUT-1high tumor cells had a median survival of only three months (log-rank p = 0.00067). The gene discussed is SLC2A1; the disease is melanoma.